Agile Therapeutics reported $8.38M in Selling and Administration Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Adma Biologics ADMA:US USD 17.75M 1.86M
Agile Therapeutics AGRX:US USD 8.38M 2.06M
Bayer BAYN:GR EUR 4.08B 393M
Biomarin Pharmaceutical BMRN:US USD 216.82M 19.98M
JAZZ PHA JAZZ:US USD 317.68M 7.99M
Johnson & Johnson JNJ:US USD 6.09B 137M
Merk MRK:US USD 2.47B 13M
Pacira Pharmaceuticals PCRX:US USD 61.28M 3.72M
Pain Therapeutics PTIE:US USD 2.82M 150K
Pfizer PFE:US USD 3.54B 345M
Teva Pharmaceutical Industries TEVA:US USD 777M 72M
Therapeuticsmd TXMD:US USD 36.76M 4.32M